PERRY DAVID P

CIK 00011059414 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001105941

Recent Transactions

47 trades

Award
Better Therapeutics, Inc.
Common Stock
2024-02-09$0.19/sh+839,895→ 2,416,634 total
Award
Better Therapeutics, Inc.
Common Stock
2024-01-09$0.17/sh+1,471,453→ 1,576,739 total
Award
Better Therapeutics, Inc.
Common Stock
2023-12-18+3,750→ 105,286 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-07-27$0.73/sh+1,233,045→ 13,030,393 total
Award
Better Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-07+15,000→ 15,000 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-04-10$0.82/sh+3,636,364→ 3,636,364 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-04-10$0.82/sh+1,333,333→ 11,797,348 total
Purchase
Better Therapeutics, Inc.
Common Stock
2022-09-16$2.07/sh+39,156→ 101,536 total
Purchase
Better Therapeutics, Inc.
Common Stock
2022-09-15$1.99/sh+10,844→ 62,380 total
Award
Better Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09+15,000→ 15,000 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-10-28$10.00/sh+200,000→ 10,730,037 total
Award
Better Therapeutics, Inc.
Common Stock
2021-10-28+293,150→ 10,508,701 total
Award
Better Therapeutics, Inc.
Common Stock
2021-10-28$10.00/sh+100,000→ 10,830,037 total
Award
Better Therapeutics, Inc.
Common Stock
2021-10-28+10,164,015→ 10,215,551 total
Award
Better Therapeutics, Inc.
Common Stock
2021-10-28+21,336→ 10,530,037 total
Award
Better Therapeutics, Inc.
Stock Option (Right to Buy)
2021-10-28+28,300→ 28,300 total
Award
Evelo Biosciences, Inc.
Stock Option (Right to Buy)
2021-06-09+1,810→ 1,810 total
Award
Evelo Biosciences, Inc.
Stock Option (Right to Buy)
2021-06-08+15,690→ 15,690 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-05-26$9.95/sh+20,000→ 51,536 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-05-24$9.94/sh+8,000→ 31,536 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-05-21$9.95/sh+8,000→ 23,536 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-05-14$9.93/sh+3,060→ 15,536 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-05-13$9.93/sh+7,000→ 12,476 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-05-04$9.93/sh+3,476→ 5,476 total
Purchase
Better Therapeutics, Inc.
Common Stock
2021-04-30$9.95/sh+2,000→ 2,000 total
Award
Evelo Biosciences, Inc.
Stock Option (Right to Buy)
2020-06-17+15,690→ 15,690 total
Award
Evelo Biosciences, Inc.
Stock Option (Right to Buy)
2019-06-12+15,690→ 15,690 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-03-05$20.24/sh−7,500→ 361,306 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-03-04$20.20/sh−7,500→ 418,806 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-03-04$20.22/sh−50,000→ 368,806 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-02-07+165,000→ 165,000 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-02-05$16.71/sh−7,500→ 426,306 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-02-04$17.29/sh−7,500→ 433,806 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-01-09$16.49/sh−7,500→ 441,306 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-01-08$16.30/sh−50,000→ 448,806 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-01-08$16.30/sh−7,500→ 498,806 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2013-12-09$0.60/sh+285,480→ 516,634 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2013-12-09$16.72/sh−10,328→ 506,306 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2013-12-09−285,480→ 0 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2013-12-06$16.58/sh−5,200→ 240,954 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2013-12-06$16.99/sh−9,800→ 231,154 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2013-12-05$15.18/sh−12,100→ 249,054 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2013-12-05$15.67/sh−2,900→ 246,154 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2013-04-12+185,000→ 185,000 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2012-03-13+125,000→ 125,000 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2011-03-31+185,000→ 185,000 total
Award
NEXPRISE INC
Non-qualified Stock Option (right to buy)
2004-04-22+1,666→ 151,930 total

Companies

Recent Filings

Address

1020 EAST MEADOW CIRCLE

PALO ALTO, CA, 94303

View on SEC.gov